StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
7727.T$768.00-2.56%
Fair $768.00+0.0%

7727.T

OVAL Corporation

Technology / Scientific & Technical InstrumentsTokyo

$768.00

-20.00 (-2.56%)

Fairly Valued+0.0%Fair Value $768.00Fund rank 36/100 · Data gapFallback financials|
SA 64/B
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 24% · confianza 25%

FCF escenarios

weak_data · normalized FCF $718.6M · quality 72.7/100

Data gap 36/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 67/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

64/100

B

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 7727.TLocal privado en este navegador · OVAL Corporation
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$15.6B

P/E

1.1x

↓

EV/EBITDA

7.1x

↓

ROE

6.5%

↑

Gross Margin

40.8%

↑

Debt/Equity

0.10

↓
52-Week Range$768
$410$915

TradingView lightweight chart

7727.T price, volumen y niveles de valoración

Último $762.00Periodo +444.3%
Fair value: $768.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+10.5%

FCF CAGR

+18.1%

FCF margin

8.2%

FCF / Net income

1.20x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $15.05B · net income $1.03B · FCF $1.23B

2022-FY → 2025-FY

Gross margin

40.8%+4.1% pts

Operating margin

9.5%+7.0% pts

Net margin

6.8%+4.3% pts

FCF margin

8.2%+1.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$15.05B$15.05B$14.35B$13.31B$11.14B
Net Income$1.03B$1.03B$1.10B$649.2M$286.0M
EBITDA$2.07B$2.07B$2.16B$1.77B$1.14B
EPS45.9645.9649.2028.9812.77
Gross Margin40.8%40.8%41.5%39.6%36.7%
Operating Margin9.5%9.5%10.3%8.3%2.5%
Net Margin6.8%6.8%7.7%4.9%2.6%
Balance Sheet
Debt/Equity0.100.100.130.160.19
Current Ratio2.952.95———
Cash Flow
Free Cash Flow$1.23B$1.23B$718.6M$207.5M$746.8M
Returns
ROE6.5%6.5%7.4%4.7%2.2%
Valuation
P/E1.081.0810.8714.9123.10
EV/EBITDA7.107.104.854.904.95
P/B1.081.080.800.700.50
Growth & Yield
Revenue Growth4.9%4.9%7.8%19.5%—
EPS Growth-6.6%-6.6%69.8%126.9%—
Dividend Yield3.7%3.7%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

14.0%

razonable

EPS terminal req.

$68.15

Spread vs growth

-20.6%

5Y implied EPS CAGR

12.4%

razonable

EPS terminal req.

$82.46

Spread vs growth

-19.0%

10Y implied EPS CAGR

11.2%

razonable

EPS terminal req.

$132.80

Spread vs growth

-17.8%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +86.8%

Total return

+86.8%

Start / end P/E

8.5x → 16.6x

EPS bridge

49.20 → 45.96

Residual

-6.3%

EPS growth-6.6%
Multiple rerating+96.1%
Dividend+3.7%
Residual / FX / buybacks / cross-term-6.3%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.